Roivant Sciences (ROIV) Return on Equity [ROE] (2021 - 2026)
Roivant Sciences (ROIV) posted Return on Equity [ROE] of -8.12% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.64 percentage points from -13.76% a year earlier but down 0.37 percentage points from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Roivant Sciences' Return on Equity [ROE] came in at -7.59%, down 1.46 percentage points from FY2025.
- Annual Return on Equity [ROE] shows a four-year change of +37.72 percentage points (FY2022 to FY2026).
- In prior fiscal years, Roivant Sciences' Return on Equity [ROE] was -6.13% in FY2025 (-111.18 pp), 105.04% in FY2024 (+166.22 pp), -61.18% in FY2023 (-15.86 pp) and -45.32% in FY2022.
- Quarterly Return on Equity [ROE] has run from a low of -91.52% in fiscal Q3 2023 to a high of 111.20% in fiscal Q3 2024 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -27.46 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q3 2024, with a gain of 202.72 percentage points; the weakest was fiscal Q3 2025, with a drop of 116.37 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -7.75% (Q4 2026), -20.57% (Q3 2026) and -11.94% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Roivant Sciences | 29.81 Bn | 13.51 Bn | 31.77 Mn | -8.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -8.11% |
| Jun 30, 2026 | -8.12% |
| Mar 31, 2026 | -7.75% |
| Dec 31, 2025 | -20.57% |
| Sep 30, 2025 | -11.94% |
| Jun 30, 2025 | -13.76% |
| Mar 31, 2025 | -6.65% |
| Dec 31, 2024 | -5.16% |
| Sep 30, 2024 | 81.35% |
| Jun 30, 2024 | 74.80% |
| Mar 31, 2024 | 64.93% |
| Dec 31, 2023 | 111.20% |
| Sep 30, 2023 | -79.66% |
| Jun 30, 2023 | -70.99% |
| Mar 31, 2023 | -70.52% |
| Dec 31, 2022 | -91.52% |
| Sep 30, 2022 | -77.51% |
| Jun 30, 2022 | -62.03% |
| Mar 31, 2022 | -43.12% |
| Dec 31, 2021 | -51.16% |
API Access
Roivant Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();